Skip Navigation

Cardiovascular Research 2003 60(2):347-354; doi:10.1016/S0008-6363(03)00529-7
© 2003 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Brady, M.
Right arrow Articles by Fuller, S. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brady, M.
Right arrow Articles by Fuller, S. J
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2003, European Society of Cardiology

Sp1 and Sp3 transcription factors are required for trans-activation of the human SERCA2 promoter in cardiomyocytes

Marc Bradya, Maren U Kobana, Kimberley A Dellowa, Magdi Yacouba, Kenneth R Bohelera,b and Stephen J Fuller*,a

aNational Heart and Lung Institute Division, Faculty of Medicine, Imperial College London, Guy Scadding Building, Dovehouse Street, London SW3 6LY, UK
bNational Institute on Aging, National Institutes of Health, Baltimore, MD, USA

*Corresponding author. Tel.: +44-207-351-8144; fax: +44-207-823-3392. Email address: stephen.fuller{at}imperial.ac.uk

Objectives: The sarcoplasmic reticulum (SR) Ca2+ ATPase (SERCA) is essential to the removal of cytosolic calcium following cardiac contraction, and its abundance and activity are significantly altered during perinatal development and in failing myocardium. The objective of the current study was to identify cis regulatory elements and nuclear transcription factors responsible for transactivating SERCA2 gene expression in cardiomyocytes. Methods: Primary cultures of neonatal rat ventricular myocytes were transiently transfected with luciferase (LUX) reporter gene constructs containing deletions of the SERCA2 promoter or which harbored mutations in consensus Sp1 transcription factor binding sites. Cotransfection assays, electrophoretic mobility shift, and supershift assays were also performed to delineate the regulatory role of specific transcription factors. Results: We identified a putative AP-1-like element and a consensus Egr-1 binding site, but neither Egr-1 nor 12-O-tetradecanoylphorbol 13-acetate (TPA) significantly modified human SERCA2 promoter activity in vitro. Maximal activity of the SERCA2 promoter required the proximal 177 bp, and strong activation was observed with a 125-bp construct, within which an Sp1 site and a CAAT box were important. Mutation analysis also revealed the importance of two Sp1 sites between –125 and –200. Sp1 and Sp3 transcription factors were subsequently identified to bind to oligonucleotide probes corresponding to only the two most proximal Sp1 sites. Conclusions: These studies provide direct evidence that regulation of human SERCA2 gene expression in cardiomyocytes depends on transactivation events elicited by Sp1 and Sp3 transcription factors.

KEYWORDS Sarcoplasmic reticulum Ca2+-ATPase; Gene expression; Cardiac myocytes; Transcription factors; Promoter

Abbreviations: β-gal, β-galactosidase • LUX, luciferase • PKC, protein kinase C • SERCA, sarcoplasmic reticulum Ca2+ ATPase • SR, sarcoplasmic reticulum • TPA, 12-O-tetradecanoylphorbol 13-acetate


Time for primary review 27 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Gambetta, M. K. Al-Ahdab, M. N. Ilbawi, N. Hassaniya, and M. Gupta
Transcription repression and blocks in cell cycle progression in hypoplastic left heart syndrome
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2268 - H2275.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Bupha-Intr and J. Wattanapermpool
Regulatory role of ovarian sex hormones in calcium uptake activity of cardiac sarcoplasmic reticulum
Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1101 - H1108.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
F. Prunier, Y. Chen, B. Gellen, M. Heimburger, C. Choqueux, B. Escoubet, J.-B. Michel, and J.-J. Mercadier
Left ventricular SERCA2a gene down-regulation does not parallel ANP gene up-regulation during post-MI remodelling in rats
Eur J Heart Fail, August 1, 2005; 7(5): 739 - 747.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.